Page 92 - CL Armchair Case

Daraprim is known generically as pyrimethamine and was

first approved by the Federal Drug Administration in 1953

The House Committee on Oversight and Investigations in

February 2016 who were looking into Turing and other drug

companies' price increases. (4) cited the following excerpts

from the company's internal documents and emails.

When Turing agreed to buy Daraprim, company officials

went into celebration mode:

"Very good. Nice work as usual. $1bn here we come." —

Turing Chairman Ron Tilles email dated May 27, 2015.

"I think it will be huge. We raised the price from $1,700 per

bottle to $75,000. ... So 5,000 paying bottles at the new price

is $375,000,000 - almost all of it is profit and I think we will

get 3 years of that or more. Should be a very handsome

investment for all of us." – Martin Shkreli email dated Aug.

27, 2015.